Providing consultancy within R&D, Innovation, Talent and Relationships, Per Falholt is Chairman of DTU, The Danish Technology University  and also Chairman of the Advisory Board for SanderMap GmbH.

With a passion for biotechnology and innovation, Per Falholt started his career as a research chemist at Novo A/S. Subsequently, Mr. Falholt held several managerial positions, eventually assuming position as Executive Vice President in R&D in Novozymes A/S. The department that has grown from 400 to 1350 employees in his 15 years as a leader, and has played a pivotal role in Novozymes’ current revenue of 12.46 billion DKK. With a global innovation rank of 59 according to Forbes and a #1 position as best employer for Scientist within Biotech & Pharma by Science magazine in October 2015, Per Falholt sets himself as a frontrunner in the fields of delivering solutions for customer needs and maintaining growth through innovation.